AllianceBernstein’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-233,117
Closed -$19.8M 3220
2019
Q4
$19.8M Buy
233,117
+84,750
+57% +$5.65M 0.01% 824
2019
Q3
$7.42M Buy
148,367
+20,690
+16% +$825K ﹤0.01% 1169
2019
Q2
$4.66M Buy
127,677
+26,700
+26% +$872K ﹤0.01% 1459
2019
Q1
$2.82M Hold
100,977
﹤0.01% 1717
2018
Q4
$1.93M Sell
100,977
-3,690
-4% -$85.8K ﹤0.01% 1848
2018
Q3
$3.13M Buy
104,667
+30
+0% +$1.13K ﹤0.01% 1618
2018
Q2
$3.84M Sell
104,637
-3,209
-3% -$104K ﹤0.01% 1433
2018
Q1
$3.55M Sell
107,846
-1,170,573
-92% -$36.6M ﹤0.01% 1417
2017
Q4
$35M Sell
1,278,419
-37,099
-3% -$1.14M 0.03% 611
2017
Q3
$48.7M Buy
1,315,518
+101,850
+8% +$3.75M 0.04% 489
2017
Q2
$46.1M Buy
1,213,668
+19,043
+2% +$848K 0.04% 499
2017
Q1
$58.4M Sell
1,194,625
-76,015
-6% -$3.47M 0.05% 429
2016
Q4
$43.1M Buy
1,270,640
+177,650
+16% +$6.3M 0.04% 494
2016
Q3
$41.2M Sell
1,092,990
-4,355
-0.4% -$164K 0.03% 502
2016
Q2
$36.9M Sell
1,097,345
-56,879
-5% -$2.01M 0.03% 505
2016
Q1
$36.7M Sell
1,154,224
-183,083
-14% -$5.98M 0.03% 509
2015
Q4
$49.9M Buy
1,337,307
+1,229,730
+1,143% +$46.5M 0.04% 442
2015
Q3
$4.08M Sell
107,577
-67,100
-38% -$2.36M ﹤0.01% 1149
2015
Q2
$5M Hold
174,677
﹤0.01% 1115
2015
Q1
$4.89M Buy
174,677
+14,110
+9% +$396K ﹤0.01% 1135
2014
Q4
$4.44M Sell
160,567
-3,600
-2% -$89.2K ﹤0.01% 1171
2014
Q3
$3.66M Buy
164,167
+31,780
+24% +$807K ﹤0.01% 1261
2014
Q2
$3.85M Hold
132,387
﹤0.01% 1298
2014
Q1
$3.76M Sell
132,387
-1
-0% -$33 ﹤0.01% 1291
2013
Q4
$5.11M Sell
132,388
-8
-0% -$286 ﹤0.01% 1100
2013
Q3
$4.44M Buy
132,396
+5,570
+4% +$177K ﹤0.01% 1135
2013
Q2
$3.9M Buy
+126,826
New +$4.24M ﹤0.01% 1137

Other funds holding MDCO

AllianceBernstein's MDCO Position: Q1 2020 in Review

AllianceBernstein sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 233,117 shares — an estimated $19.8M sold.

AllianceBernstein first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $58.4M in Q1 2017. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • AllianceBernstein reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • AllianceBernstein sold 233,117 Medicines Co shares in Q1 2020, an estimated $19.8M.
  • AllianceBernstein first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
  • AllianceBernstein's Medicines Co position peaked at $58.4M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on AllianceBernstein's 13F filing for Q1 2020, filed 14 May 2020.